AMP-activated protein kinase deficiency enhances myocardial ischemia/reperfusion injury but has minimal effect on the antioxidant/antinitrative protection of adiponectin.
about
S100A1 is released from ischemic cardiomyocytes and signals myocardial damage via Toll-like receptor 4Therapeutic impact of follistatin-like 1 on myocardial ischemic injury in preclinical modelsConcerted regulation of cGMP and cAMP phosphodiesterases in early cardiac hypertrophy induced by angiotensin IIGlobular adiponectin, acting via AdipoR1/APPL1, protects H9c2 cells from hypoxia/reoxygenation-induced apoptosisAdiponectin deficiency exacerbates cardiac dysfunction following pressure overload through disruption of an AMPK-dependent angiogenic response.The vestigial enzyme D-dopachrome tautomerase protects the heart against ischemic injury.Reduced vascular responsiveness to adiponectin in hyperlipidemic rats--mechanisms and significance.The outcome of renal ischemia-reperfusion injury is unchanged in AMPK-β1 deficient mice.A novel and efficient model of coronary artery ligation and myocardial infarction in the mouse.Liver X receptor agonist treatment attenuates cardiac dysfunction in type 2 diabetic db/db mice.FoxO transcription factors promote cardiomyocyte survival upon induction of oxidative stress.T-cadherin is essential for adiponectin-mediated revascularizationCardiac-specific overexpression of GTP cyclohydrolase 1 restores ischaemic preconditioning during hyperglycaemiaSystemic adiponectin malfunction as a risk factor for cardiovascular diseaseReduced cardioprotective action of adiponectin in high-fat diet-induced type II diabetic mice and its underlying mechanisms.Glycolytic rate and lymphomagenesis depend on PARP14, an ADP ribosyltransferase of the B aggressive lymphoma (BAL) family.G-protein-coupled receptor kinase 2-mediated desensitization of adiponectin receptor 1 in failing heart.Myocardial injury after ischemia-reperfusion in mice deficient in Akt2 is associated with increased cardiac macrophage densityEssential role of caveolin-3 in adiponectin signalsome formation and adiponectin cardioprotection.Adiponectin and cardiovascular health: an updateAdipoRon, the first orally active adiponectin receptor activator, attenuates postischemic myocardial apoptosis through both AMPK-mediated and AMPK-independent signalings.Adiponectin action: a combination of endocrine and autocrine/paracrine effects.C1q/tumor necrosis factor-related protein-3, a newly identified adipokine, is a novel antiapoptotic, proangiogenic, and cardioprotective molecule in the ischemic mouse heartAcetylcholine ameliorates endoplasmic reticulum stress in endothelial cells after hypoxia/reoxygenation via M3 AChR-AMPK signalingHigh glucose/High Lipids impair vascular adiponectin function via inhibition of caveolin-1/AdipoR1 signalsome formation.Regional evidence of modulation of cardiac adiponectin level in dilated cardiomyopathy: pilot study in a porcine animal model.Salidroside exerts protective effects against chronic hypoxia-induced pulmonary arterial hypertension via AMPKα1-dependent pathways.Lymphotoxin-α is a novel adiponectin expression suppressor following myocardial ischemia/reperfusion.Adiponectin, the past two decades.Adiponectin enhances bone marrow mesenchymal stem cell resistance to flow shear stress through AMP-activated protein kinase signalingAntihyperglycaemic activity of 2,4:3,5-dibenzylidene-D-xylose-diethyl dithioacetal in diabetic mice.Cardioprotective effect of adiponectin is partially mediated by its AMPK-independent antinitrative action.Adiponectin inhibits oxidative/nitrative stress during myocardial ischemia and reperfusion via PKA signaling.Adenosine Monophosphate-Activated Protein Kinase (AMPK) as a New Target for Antidiabetic Drugs: A Review on Metabolic, Pharmacological and Chemical Considerations.Adiponectin inhibits tumor necrosis factor-α-induced vascular inflammatory response via caveolin-mediated ceramidase recruitment and activation.AMPK - Activated Protein Kinase and its Role in Energy Metabolism of the Heart.Adiponectin and adipocyte fatty acid binding protein in the pathogenesis of cardiovascular disease.Autophagy, myocardial protection, and the metabolic syndrome.Adipokines and the cardiovascular system: mechanisms mediating health and disease.Roles of adiponectin and oxidative stress in obesity-associated metabolic and cardiovascular diseases.
P2860
Q28240188-9AF331A5-24A9-4087-B00F-A757F1E99170Q28273799-711C00D1-787B-4DBE-ADE2-A07C9225AD01Q33769656-719E09DD-8507-4EE1-A581-2F1C9204BEBEQ33892702-B322EED5-4911-4135-BFF0-165AC9081931Q33912715-501460E4-D3BF-4927-8ECF-A2F03B7979A7Q33944140-170F0A3C-DC36-48C6-B557-538F1E4E19DEQ33998524-D0FFC0B2-7A5F-4505-949D-D56ACB57953EQ34130765-0EE558BB-21C9-4071-92ED-B74D5B757DCEQ34423842-BF1C25BA-9F84-463D-8DC7-F5AA81CAB21AQ34579301-1A4AE090-AF9C-4EE1-9355-821F8C94038EQ34606366-B3061B27-0111-4E29-AB02-61046F1D3801Q34793130-AE9A23E9-D031-444F-B9D3-E875B6633500Q35073570-EABCE0C0-1A90-4332-99FA-948C8B9280DFQ35173604-CBF474DE-B40E-4B07-A17D-DD38220882E3Q35173617-B8BF5358-00CE-468B-8036-433BFF556D2EQ35229366-6FB2D4D1-41B2-43B6-BEC5-2AF21A961116Q35528402-CF980486-A7CC-48BD-AC88-B0DDDBEF8815Q35543463-71D4A755-BAC6-48A5-959E-A4CD69B3FF2EQ35853499-5F8373DA-5C12-42F0-98BD-075E166A5156Q35859734-7103B7FD-2F28-4F6F-A1A1-3089D38DF59FQ35916840-3988992D-AFDC-4EFF-A6BC-8F07BB607C23Q35971216-53CFF532-49C9-4865-BFC9-1A13AB90DA87Q36080823-0DCFCB6D-1A8E-4F06-AE32-D79B62CCF09FQ36184518-48DEEEF3-12C7-4D2B-9488-F1055B84650EQ36386345-C6C9F5C8-D54A-489A-A266-FB63B0B95B61Q36510256-5A0BA6FD-7E7A-4924-95F2-2090EE6A6365Q36595077-2EA57428-4BB1-479C-99C4-43F4E4B32E66Q36699758-8AF23CE1-1424-48D5-AC3A-B8ACACA99F12Q36751668-80372D24-D954-416B-AE39-64943429ACF4Q37096440-99DF7ED5-7EFD-4978-A0AC-DDD36777868CQ37294824-C42E858F-E756-450C-9ACC-7513AEE5E9DDQ37298116-A0E99F5F-60EB-4E75-A5D5-31BF19600AC9Q37439800-FDEBB704-793C-4797-9CCF-E62A119A242FQ37531997-4B531075-B4D9-4544-A8EF-FBEC57360F74Q37653646-0C979545-04B6-4923-814B-17C06931E739Q37951443-42EC838C-F2E7-462A-9D78-1DC08CD846BCQ37972596-ECF183FD-FC00-4D00-A7F7-D1C690F7F8BBQ37999635-3762EDE2-742E-4E15-BD52-5E0E3B3080F2Q38014474-D0E0CFD5-9A60-4628-AEF0-F3FEF9FAAC5FQ38136560-044635F0-5FAC-47CF-B958-FB0D3E422C49
P2860
AMP-activated protein kinase deficiency enhances myocardial ischemia/reperfusion injury but has minimal effect on the antioxidant/antinitrative protection of adiponectin.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 02 February 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
AMP-activated protein kinase d ...... ive protection of adiponectin.
@en
AMP-activated protein kinase d ...... ive protection of adiponectin.
@nl
type
label
AMP-activated protein kinase d ...... ive protection of adiponectin.
@en
AMP-activated protein kinase d ...... ive protection of adiponectin.
@nl
prefLabel
AMP-activated protein kinase d ...... ive protection of adiponectin.
@en
AMP-activated protein kinase d ...... ive protection of adiponectin.
@nl
P2093
P2860
P50
P1433
P1476
AMP-activated protein kinase d ...... ive protection of adiponectin.
@en
P2093
Barry J Goldstein
Bernard L Lopez
Theodore A Christopher
Walter Koch
Xin-Liang Ma
Yajing Wang
Yuexin Yuan
P2860
P304
P356
10.1161/CIRCULATIONAHA.108.815043
P407
P577
2009-02-02T00:00:00Z